Navigation Links
Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
Date:4/10/2008

Next generation test for individuals with systemic lupus erythematosus and

lupus-like disorders expands Corgenix' extensive portfolio of

antiphospholipid products

DENVER, April 10 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX) announced receipt of 510(k) clearance by the United States Food and Drug Administration (FDA) for the Company's IgG Anti-AtherOx(R) Test Kit. This new laboratory test, now available worldwide, utilizes the Company's patented AtherOx(R) technology to detect antibodies in individuals with important autoimmune diseases.

Research data presented at several medical and scientific meetings has shown the association of antibodies to the AtherOx (R) complex with vascular thrombosis (particularly arterial thrombosis) in patients with autoimmune diseases. Studies published in The Journal of Clinical and Developmental Immunology (2003) and The American Journal of Pathology (2004) showed that by testing serum samples from lupus patients for a series of risk factors, it was concluded the measurement of the AtherOx(R) antibody was significantly better than conventional anti-cardiolipin testing in identifying patients with vascular complications, and illustrated a pivotal role of B2-glycoprotein I (B2GPI) in vascular injury and thrombosis.

"This test will be an important addition to our other phospholipid products currently used worldwide by physicians to identify patients with thrombosis-associated antibodies," said Luis Lopez, M.D., Corgenix' Chief Medical Officer. "It provides vital clinical information for physicians treating individuals with SLE and antiphospholipid syndrome, both of which are very important clinical problems."

Douglass Simpson, Corgenix' President and Chief Executive Officer said, "We are pleased to receive FDA clearance for this important product. Corgenix has a long history of developing and bringing to market innovative products for
'/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago
2. Corgenix Signs Technology Licensing Agreement With Japanese Government
3. Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
4. Oncothyreon announces effectiveness of shelf registration statement
5. Novagali Pharma Announces the Launch of Cationorm(R)
6. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
7. Dendreon Announces Closing of Registered Direct Offering
8. Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled Bipolar Trans Carotenoid Salts and Their Uses, for Its Family of First-In-Class Molecules
9. Caliper Life Sciences Announces Date and Location of its 2008 Annual Meeting of Stockholders
10. Cylex Announces Brad L. Stewart as President of the Company
11. Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... York, NY (PRWEB) October 23, 2014 ... announced the winners for the 2014 BioProcess International ... business strategies, social corporate responsibility and technology applications ... more effective treatments to a global patient base. ... by their peers during a very entertaining and ...
(Date:10/25/2014)... (PRWEB) October 24, 2014 DuPont ... plans to more than double the acreage contracted ... geographies supplying its soybean crush facility in Salisbury, ... this program will target several markets including foodservice ... with good performance. , For the 2015 growing ...
(Date:10/25/2014)... October 24, 2014 This research ... PBS, Starch Based Plastics, Regenerated Cellulose, PCL), by ... Trends and Forecasts to 2019”, defines and segments ... and forecast of its global volume and value. ... Figures spread through 178 Slides and in-depth TOC ...
(Date:10/25/2014)... October 24, 2014 SonaCare Medical, ... ultrasound (HIFU) technology, announced that its Board of ... Chief Executive Officer, President and member of the ... Carol will take-on expanded responsibilities within the company, ... well as overseeing commercialization, manufacturing and finance. ...
Breaking Biology Technology:BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 2DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 3DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program 4Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 2Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 3Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 4SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3
... intense scrutiny that started in September when Vioxxs manufacturer ... concerns, the U.S. Food and Drug Administration and the ... the biggest challenges has been the pipeline problem, the ... innovative medical therapies reaching patients. In its March ...
... Much of Thursday's Digital Healthcare Conference in ... of them. , ,In today's issue, the first of ... Digital Healthcare Conference, you'll read about the technology choices ... those choices. Next issue, look for coverage of the ...
... While Wisconsin may be ahead of the ... way to go before full use of electronic health ... the recognized quality improvements and long-term cost savings, implementation ... the Internet Business Solutions Group Healthcare Practice ...
Cached Biology Technology:Challenging times for FDA and drug companies equals IT opportunities 2Challenging times for FDA and drug companies equals IT opportunities 3The tough choices facing health care 2The tough choices facing health care 3Organizations finding ways to overcome barriers to electronic health records implementation 2Organizations finding ways to overcome barriers to electronic health records implementation 3Organizations finding ways to overcome barriers to electronic health records implementation 4
(Date:10/17/2014)... Ebola is critical and pertinent for practicing physicians and ... and epidemic. The Journal, Disaster Medicine and Public ... Virus and Public Health, to surround the public, medical ... societal moment. , On October 17, the journal ... The primer was prepared by Dr. Eric Toner, internist ...
(Date:10/17/2014)... release is available in German . ... a very few drugs. When treating overdoses, doctors are often ... especially difficult if there is a combination of drugs involved. ... and accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux ... to find an answer to this question. "The task was ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
... memory functions and how memories could potentially be erased ... legal scholars will explore the neuroethics of memory at ... Friday, December 9, at the SUNY Global Center, 116 ... The speakers are Andr A. Fenton, PhD, New ...
... since the United States entered World War II after the ... new look at an often overlooked breed of soldier. ... beyond the battlefield duties of these four-legged soldiers and captures ... mobilized their people to their nations, causes. "It may ...
... This press release is available in German ... Foundation) will establish eight Collaborative Research Centres (CRC) as of ... Committee at its autumn meeting in Bonn. The new CRCs ... 20 percent programme allowance for indirect project costs) in their ...
Cached Biology News:Dogs of war: Historian shows the role of canines in World War II 2DFG to fund 8 new collaborative research centers 2DFG to fund 8 new collaborative research centers 3DFG to fund 8 new collaborative research centers 4DFG to fund 8 new collaborative research centers 5
BD BioCoat Laminin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
BD BioCoat Matrigel Matrix 35 mm Culture Dishes Coating : BD MatrigelTM Basement Membrane Matrix ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vo...
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... Cytokeratin TYPE II Reacts with most ... epidermal cell keratin of 86 and 58kD ... Broad keratin reactivity is found on human ... Immunogen: Human epidermal cells ...
Biology Products: